Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Industrifonden and ACTIVE Venture Partners in connection with Barnebys.se investment
Mandate

Vinge advises Industrifonden and ACTIVE Venture Partners in connection with Barnebys.se investment

October 09, 2012

Vinge has advised Industrifonden and ACTIVE Venture Partners in connection with their total investment of MSEK 9 in Barnebys.se, a search engine for auctions. The capital contribution will primarily be used for international expansion, starting with the UK as well as for continued business development.

Industrifonden invests in small and medium-sized companies with international growth potential. The fund has assets of SEK 3.6 billion and has invested in approximately 90 companies within the technology, cleantech, life science and industrial sectors.

ACTIVE Venture Partners is a European venture capital firm helping technology companies in the start-up and expansion phases of their development. The firm was founded in 2002 and has its registered office in Barcelona. ACTIVE currently manages two funds with a total value of EUR 75 million.

Vinge’s team primarily consisted of partner Johan Larsson and associate Nicolina Kindblom.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025